IQVIA, Eurofins Scientific, SGS SA Are Dominating the Global Medical Device Outsourcing In 2020

Global Medical Device Outsourcing is expected to grow with the CAGR of 6.7% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @

Global medical device outsourcing is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global medical device outsourcing are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced reprocessed services and product portfolio.

For instance, In November 2020, MDBriefCase and IQVIA collaborated to provide access to specialize e-learning and engagement for HCPs in the Middle East, Africa and South Asia. This extended the services to include MDBC’s suite of online medical education and training solutions and global content development expertise.

IQVIA is the dominating player in global medical device outsourcing market. The other key players existing in the market are SGS SA , TOXIKON, Pace Analytical, Intertek Group plc, WuXi AppTec, North American Science Associates, Inc., American Preclinical Services, LLC., Sterigenics U.S., LLC – A Sotera Health company, Charles River Laboratories, Celestica Inc., Creganna, FLEX LTD., Heraeus Holding, Integer Holdings Corporation, Nortech Systems, Inc., Plexus Corp., Sanmina Corporation, EUROFINS SCIENTIFIC, TE Connectivity, ICON plc, Parexel International Corporation, Labcorp Drug Development, Tecomet, Inc., IQVIA, Jabil Inc. Syneos Health, PROVIDIEN LLC.,   Cekindo Business International East/West Industries, Inc., TÜV SÜD among others.among others.

Medical Device Outsourcing MarketIQVIA

IQVIA is headquartered in Connecticut U.S. which was established in 1982. . The company focuses on providing advanced analytics, technology solutions and clinical research services  to the life sciences  industry and delivers  powerful  insights  with  speed  and  agility — enabling  customers  to accelerate  the clinical development and commercialization of innovative medical treatments  that improve healthcare outcomes for patients. The industry categories of the company include Pharmaceutical Manufacturers, Emerging Biopharma, Consumer Health, MedTech, Generics, Information Partner Services, Financial Institutions, Public Health and Government, Patient Associations, Payers and Providers out of which MedTech is the market focused category.

  • In July 2021, BREATHE and IQVIA collaborated to accelerate the early diagnosis and treatment of respiratory conditions. This strategic step of working together to improve health outcomes and quality of life for people living with respiratory conditions in the U.K. would ramp up the market.

The company has presence in Americas, Asia-Pacific and Oceania, Europe, Middle East and Africa. In addition to it, the company also generates its revenue from the various subsidiary companies such as  AIECO IT Solutions India Private Ltd. (India), Albatross Financial Solutions Limited (U.K.), ALIMED Egeszsegugyi Szolgaltato Kft. (Hungary), APPATURE, INC. (Washington), Asserta Centroamerica Medicion de Mercados, S.A. (Guatemela), Battaerd Mansley (Proprietary) Limited (South Africa), Battaerd Mansley Pty. Ltd. (Australia), Benefit Canada, Inc. (Canada), Benefit Holding, Inc. (North Carolina), BUZZEOPDMA LLC (Delaware) among others.  .


Eurofins Scientific is headquartered in Nantes Franceand was founded in 1987. The company is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and the environment safer, healthier and more sustainable. The product categories of the company include AgroScience Services, Agro Testing, Assurance, BioPharma Services, Clinical Diagnostic, Consumer Product Testing, Cosmetics and Personal Care, Environmental Testing, Food and Feed Testing, Genomic Services, Maritime Services, Forensic Services, REACH Services, Materials and Engineering, Eurofins Technologies out of which BioPharma Services is the market focused category.

  • In May 2018, Eurofins Scientific had increased the biopharmaceutical products testing footprint with an outsourcing agreement with Astellas in Japan. The product expansion took place due to the company forming an agreement with Astellas to outsource the internal testing laboratories named as Astellas Analytical Science Laboratories, Inc. (“ASL”). ASL has offered the test services with good manufacturing practices in Japan. The outsourcing had expanded the growing footprint in Asia Pacific, and provides a good platform to further expand in the biopharmaceutical products testing market in Asia.

The company has wide global presence across Americas, Europe, Asia-Pacific, Middle East and Africa. In addition to it, the company also generates its revenue from the various subsidiary companies such as Eurofins Food Testing UK Limited (U.K.), Eurofins Biomnis (France), Megalab SA (Spain), EAG (California), DiscoveRx (California) among others. 


SGS SA. is headquartered in Geneva, Switzerland and was founded in year 1870. The company is the world’s leading testing, inspection and certification company. The product categories of the company include Connectivity & Products, Digital Solutions, Industries & Environment, Health & Nutrition, Knowledge Solutions, Natural Resources, Sustainability Solutions out of which Health & Nutrition is the market focused category.

  • In May 2020, SGS SA has expanded the Network of ISTA Labs and Adds ISTA’s 6-Amazon Certification Testing. The service expansion meant to maintain the package testing standards while outsourcing the medical devices and the need to protect products from damage throughout the supply chain without the need for additional packaging.

The company has wide global presence across Americas, Europe, Middle East and Africa, Asia-Pacific.